Fluconazole Prophylaxis in Neonates (Non-Systematic) Literature Review
- 1 College of Pharmacy, University of Arizona, Tucson, AZ, USA
Abstract
Background: Nosocomial infection remains an important contributing factor for morbidity and mortality in neonates. Coagulase-negative staphylococci have emerged as the predominant pathogens of late onset sepsis. This is followed by staphylococcus aurous, gram negative bacilli, and fungi. Old studies noted that mortality due to candidemia was higher in infants weigh less than 2000 g after being exposed to risk factors. The prophylactic use of fluconazole for the prevention of IC in extremely low birth weight was first reported in 2001. Methods: Current guidelines from Europe and North America that refer to the treatment of fungal infections are included. Literature search was performed using Medline, Scopus and Cochrane Central Register of Controlled Trials through March, 2016. Conclusion: Mortality was not different in early studies. However, recent studies concluded that mortality was reduced in the fluconazole arms. Risk-based approach towards fluconazole prophylaxis seems to be safe and effective.
- Weese-Mayer, D.E., Fondriest, D.W., Brouillette, R.T. and Shulman, S.T. (1987) Risk Factors Associated with Candidemia in the Neonatal Intensive Care Unit: A Case-Control Study. The Pediatric Infectious Disease Journal, 6, 190-196. https://doi.org/10.1097/00006454-198702000-00009
- Singhi, S., Rao, D.S. and Chakrabarti, A. (2008) Candida Colonization and Candidemia in a Pediatric Intensive Care Unit. Pediatric Critical Care Medicine, 9, 91-95. https://doi.org/10.1097/01.PCC.0000298643.48547.83
- Saiman, L., Ludington, E., Dawson, J.D., et al. (2001) Risk Factors for Candida Species Colonization of Neonatal Intensive Care Unit Patients. The Pediatric Infectious Disease Journal, 20, 1119-1124. https://doi.org/10.1097/00006454-200112000-00005
- Dong, Y., Speer, C.P. (2015) Late-Onset Neonatal Sepsis: Recent Developments. Archives of Disease in Childhood Fetal and Neonatal Edition, 100, F257-F263. https://doi.org/10.1136/archdischild-2014-306213
- Kaufman, D., Boyle, R., Hazen, K.C., Patrie, J.T., Robinson, M. and Donowitz, L.G. (2001) Fluconazole Prophylaxis against Fungal Colonization and Infection in Preterm Infants. The New England Journal of Medicine, 345, 1660-1666. https://doi.org/10.1056/NEJMoa010494
- Saiman, L., Ludington, E., Pfaller, M., et al. (2000) Risk Factors for Candidemia in Neonatal Intensive Care Unit Patients. The National Epidemiology of Mycosis Survey Study Group. The Pediatric Infectious Disease Journal, 19, 319-324. https://doi.org/10.1097/00006454-200004000-00011
- Hope, W.W., Castagnola, E., Groll, A.H., et al. (2012) ESCMID* Guideline for the Diagnosis and Management of Candida Diseases 2012: Prevention and Management of Invasive Infections in Neonates and Children Caused by Candida spp. Clinical Microbiology and Infection, 18, 38-52. https://doi.org/10.1111/1469-0691.12040
- Benjamin, D.K., Stoll, B.J., Gantz, M.G., et al. (2010) Neonatal Candidiasis: Epidemiology, Risk Factors, and Clinical Judgment. Pediatrics, 126, e865-e873. https://doi.org/10.1542/peds.2009-3412
- Rolnitsky, A., Levy, I., Sirota, L., Shalit, I. and Klinger, G. (2012) Targeted Fluconazole Prophylaxis for High-Risk Very Low Birth Weight Infants. European Journal of Pediatrics, 171, 1481-1487. https://doi.org/10.1007/s00431-012-1760-2
- Manzoni, P., Stolfi, I., Pugni, L., et al. (2007) A Multicenter, Randomized Trial of Prophylactic Fluconazole in Preterm Neonates. The New England Journal of Medicine, 356, 2483-2495. https://doi.org/10.1056/NEJMoa065733